Gabrielle Kelly

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan et al. · Immunity · 2020 · 169 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Activating Receptor Cd226 +9

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Adi Idris, Alicia Davis, Aroon Supramaniam et al. · Molecular Therapy · 2021 · 159 citations · Full text

Nanomedicine, Antiviral Therapy, Virology +4

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris et al. · Science Advances · 2021 · 47 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +17

Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2

Tristan Scott, Aroon Supramaniam, Adi Idris et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 41 citations · Full text

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection

Aroon Supramaniam, Yaman Tayyar, Daniel Clarke et al. · Journal of Microbiology Immunology and Infection · 2023 · 23 citations · Full text